• OPEN AN ACCOUNT
Indian Indices
Sensex
71,924.68 -547.65
( -0.76%)
Global Indices
Nasdaq
51,875.59 199.64
(0.39%)
Dow Jones
7,829.18 -3.36
(-0.04%)
Hang Seng
69,084.74 42.63
(0.06%)
Nikkei 225
10,644.02 91.97
(0.87%)
Forex
USD-INR
96.78 0.11
(0.12%)
EUR-INR
108.39 0.07
(0.07%)
GBP-INR
127.86 0.00
(0.00%)
JPY-INR
0.61 0.00
(0.21%)

EQUITY - MARKET SCREENER

Alembic Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
533573
INE901L01018
285.6722314
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
APLLTD
19.62
15482.29
EPS(TTM)
Face Value()
Div & Yield %
40.14
2
1.52
 

Kemp & Co reports standalone net loss of Rs 1.01 crore in the March 2026 quarter
May 26,2026
Net Loss of Kemp & Co reported to Rs 1.01 crore in the quarter ended March 2026 as against net loss of Rs 0.37 crore during the previous quarter ended March 2025. Sales rose 9.21% to Rs 0.83 crore in the quarter ended March 2026 as against Rs 0.76 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 2.21 crore in the year ended March 2026 as against net loss of Rs 1.10 crore during the previous year ended March 2025. Sales rose 3.09% to Rs 3.00 crore in the year ended March 2026 as against Rs 2.91 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales0.830.76 9 3.002.91 3
OPM %-242.17-34.21 --103.00-48.80 -
PBDT-0.74-0.26 -185 -1.72-1.15 -50
PBT-1.10-0.28 -293 -2.15-1.24 -73
NP-1.01-0.37 -173 -2.21-1.10 -101